FDA Approves First New Cholesterol Pill | Duluth News

FDA just approved Merck’s groundbreaking cholesterol drug Lipfendra — the first of its kind designed to slash cholesterol in high-risk heart patients by targeting a key protein. It offers a new weapon for those who don’t respond to existing treatments, potentially reshaping cardiovascular care and helping millions live longer, healthier lives. Now the real test begins: how well it performs in real-world use and how doctors integrate it into patient care. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a3ea70e0fd049778